SUPPLY OF 150,000 DOSES OF FIFTEEN-VALENT CONJUGATED PNEUMOCOCCAL VACCINE FOR THE YEAR 2026

This tender concerns the acquisition of 150,000 doses of a fifteen-valent conjugated pneumococcal vaccine intended for use in the year 2026. The primary purpose of this vaccine supply is for the vaccination of infants under one year of age, following a standard three-dose schedule. Additionally, the vaccine will be used for catch-up vaccinations for individuals under 18 years old, in accordance with the recommendations outlined in the Community of Madrid's 2025 Lifetime Vaccination Schedule, as issued by the Directorate General of Public Health. The procurement is being conducted under Article 16.3.a) of the Public Sector Contracts Law (L.C.S.P.), which means the proposed quantities are estimates, and actual delivery will be contingent upon the specific needs of the Directorate General of Public Health. This tender is critical for public health initiatives aimed at preventing pneumococcal diseases in vulnerable populations within the Community of Madrid.

This is a supplies contract in the health and medical services sector, with a focus on Vaccines. Located in Spain, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 6.5 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.